Dual Pathway Inhibition in Stable Cardiovascular Disease: It Takes Two to Tango!

J Cardiovasc Pharmacol. 2024 Aug 1;84(2):152-154. doi: 10.1097/FJC.0000000000001599.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Animals
  • Cardiovascular Agents / adverse effects
  • Cardiovascular Agents / therapeutic use
  • Cardiovascular Diseases* / drug therapy
  • Cardiovascular Diseases* / metabolism
  • Cardiovascular Diseases* / physiopathology
  • Drug Therapy, Combination
  • Humans
  • Signal Transduction / drug effects
  • Treatment Outcome

Substances

  • Cardiovascular Agents